1.8900
+0.0100
+(0.53%)
As of 1:36:08 PM EDT. Market Open.
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Operating Expense
3,141.6460
3,557.7250
2,996.2210
1,080.0320
891.5380
Operating Income
-3,141.6460
-3,557.7250
-2,996.2210
-1,080.0320
-891.5380
Net Non Operating Interest Income Expense
-366.7720
-385.3160
-342.4080
-309.3330
-273.3070
Other Income Expense
-44.9210
22.7530
11.9010
-18.4920
-4.8630
Pretax Income
-3,553.3390
-3,920.2880
-3,326.7280
-1,407.8570
-1,164.8450
Net Income Common Stockholders
-3,553.3390
-3,920.2880
-3,326.7280
-1,407.8570
-1,164.8450
Diluted NI Available to Com Stockholders
-3,553.3390
-3,920.2880
-3,326.7280
-1,407.8570
-1,164.8450
Basic EPS
-0.06
-0.06
-0.05
-0.02
-0.02
Diluted EPS
-0.06
-0.06
-0.05
-0.02
-0.02
Basic Average Shares
63,999.3060
63,380.5170
62,465.8000
62,158.6110
61,323.2060
Diluted Average Shares
63,999.3060
63,380.5170
62,465.8000
62,158.6110
61,323.2060
Total Operating Income as Reported
-3,512.4900
-3,947.1130
-3,355.1590
-1,389.3650
-1,164.8450
Total Expenses
3,141.6460
3,557.7250
2,996.2210
1,080.0320
891.5380
Net Income from Continuing & Discontinued Operation
-3,553.3390
-3,920.2880
-3,326.7280
-1,407.8570
-1,164.8450
Normalized Income
-3,501.6090
-3,936.2320
-3,338.6290
-1,389.3650
-1,164.8450
Interest Income
--
4.0720
16.5300
--
--
Interest Expense
370.8440
389.3880
358.9380
309.3330
273.3070
Net Interest Income
-366.7720
-385.3160
-342.4080
-309.3330
-273.3070
EBIT
-3,182.4950
-3,530.9000
-2,967.7900
-1,098.5240
-891.5380
EBITDA
-3,182.4950
-3,530.9000
-2,967.7900
-1,098.5240
-891.5380
Net Income from Continuing Operation Net Minority Interest
-3,553.3390
-3,920.2880
-3,326.7280
-1,407.8570
-1,164.8450
Total Unusual Items Excluding Goodwill
-51.7300
15.9440
11.9010
-18.4920
-4.8630
Total Unusual Items
-51.7300
15.9440
11.9010
-18.4920
-4.8630
Normalized EBITDA
-3,130.7650
-3,546.8440
-2,979.6910
-1,080.0320
-891.5380
9/30/2021 - 5/7/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AGW0.F Algernon Pharmaceuticals Inc.
0.0270
-34.15%
ITMC Itoco Inc.
0.0020
+11.11%
ENBI.CN Entheon Biomedical Corp.
0.1300
0.00%
AGN.CN Algernon Pharmaceuticals Inc.
0.0850
+6.25%
GLOW.CN Glow Lifetech Corp.
0.0650
0.00%
NGEN.V NervGen Pharma Corp.
2.7900
-0.36%
PHRM.CN PharmaTher Holdings Ltd.
0.1900
0.00%
MIR.V MedMira Inc.
0.0950
+18.75%
MDMA.CN Pharmala Biotech Holdings Inc.
0.1600
-5.88%
CYBN.NE Cybin Inc.
9.40
+16.19%